Clinical Efficacy and Safety of Apatinib Combined With S-1 in Advanced Esophageal Squamous Cell Carcinoma

Investigational New Drugs - Netherlands
doi 10.1007/s10637-019-00866-5
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

P1.13-21 Clinical Efficacy and Safety of Apatinib Combined With EGFR - TKIs in Advanced Non-Small Cell Lung Cancer With EGFR - TKIs Resistance

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Table 1: Clinical Characteristics of 80 Patients With Esophageal Squamous Cell Carcinoma.

English

Combined Fibrinogen and Neutrophil-Lymphocyte Ratio as a Prognostic Marker of Advanced Esophageal Squamous Cell Carcinoma

Cancer Science
Cancer ResearchMedicineOncology
2017English

OA08 Efficacy and Safety of Sintilimab Combined With 1st Line Chemotherapy in Advanced Squamous Cell Non-Small Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Expression and Clinical Significance of Apollon in Esophageal Squamous Cell Carcinoma

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2016English

Clinical Correlation of Nuclear Survivin in Esophageal Squamous Cell Carcinoma

Medical Oncology
MedicineCancer ResearchOncologyHematology
2012English

P3.01-49 Effciency of Low-Dosage Apatinib Monotherapy in Treatment of Advanced Lung Squamous Cell Carcinoma

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Clinical Significance of microRNA-24 Expression in Esophageal Squamous Cell Carcinoma

Neoplasma
Cancer Research
2015English

P3.01-48 the Efficiency of Low-Dose Apatinib in Treatment of Advanced Lung Squamous Cell Carcinoma

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy